Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Essex Bio-Technology Limited

Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1%
From Essex Bio-Technology Limited
Via ACN Newswire
Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22%
From Essex Bio-Technology Limited
Via ACN Newswire
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed
From Essex Bio-Technology Limited
Via ACN Newswire
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore
From Essex Bio-Technology Limited
Via ACN Newswire
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China
From Essex Bio-Technology Limited
Via ACN Newswire
Essex Bio-Technology Announces 2022 Annual Financial Results
From Essex Bio-Technology Limited
Via ACN Newswire
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
From Essex Bio-Technology Limited
Via ACN Newswire
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases
From Essex Bio-Technology Limited
Via ACN Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.